The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance.
The amount of pyruvate dehydrogenase in the active form (PDHa) was increased 1.7-fold compared with controls in heart muscle of mice 1 week after induction of obesity with a single injection of gold-thioglucose. At 4 weeks post injection, the amount of PDHa was decreased to 32% of control, a value which was observed in later stages of the obesity syndrome. In contrast, liver PDHa was increased and remained at an increased activity during the development of obesity. Despite normal post-prandial serum insulin contents, liver membrane insulin-receptor numbers were decreased 1 week after gold-thioglucose injection, and there was no change in receptor affinity. The decrease in heart PDHa in the obese animals was reversed by a single dose of 2-tetradecylglycidic acid, but this inhibitor of mitochondrial fatty acid oxidation did not affect liver PDHa in these animals. These early and diverse changes in PDHa argue for a multifactorial aetiology in the development of the whole-body insulin resistance seen in older gold-thioglucose-treated obese animals.
D000818:Animals; D006051:Aurothioglucose; D004852:Epoxy Compounds / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007333:Insulin Resistance; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009206:Myocardium / Q000201:enzymology*; D009765:Obesity / Q000139:chemically induced / Q000201:enzymology*; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism*
D004852:Epoxy Compounds; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D011768:Pyruvate Dehydrogenase Complex; D006051:Aurothioglucose; C021756:2-tetradecylglycidic acid